STRATA Skin Sciences (SSKN)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	8.40 mm	8.40 mm	8.40 mm	8.40 mm	8.40 mm	8.40 mm
Cash burn (monthly)	(no burn)	5.75 k	551.00 k	705.75 k	100.67 k	(no burn)
Cash used (since last report)	n/a	25.25 k	2.42 mm	3.10 mm	442.07 k	n/a
Cash remaining	n/a	8.37 mm	5.98 mm	5.30 mm	7.95 mm	n/a
Runway (months of cash)	n/a	1455.8	10.8	7.5	79.0	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2024

SSKN institutional ownership history Ownership history

13F holders	Current	Prev Q	Change
Total holders	17	24	-29.2%
Opened positions	2	21	-90.5%
Closed positions	9	0	NEW
Increased positions	0	0
Reduced positions	14	0	NEW

13F shares	Current	Prev Q	Change
Total value	3.28 bn	3.77 bn	-13.1%
Total shares	6.44 mm	16.40 mm	-60.8%
Total puts	0.00	0.00
Total calls	0.00	0.00
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change
22NW Fund	5.37 mm	$3.12 mm	0.0%
22NW	537.00 k	$1.65 bn	-90.0%
Nantahala Capital Management	303.92 k	$933.03 mm	-90.2%
Renaissance Technologies	105.62 k	$324.26 mm	-90.1%
Vanguard	85.82 k	$263.46 mm	-90.0%
Geode Capital Management	14.74 k	$45.27 mm	-87.8%
Creative Planning	10.02 k	$30.75 mm	NEW
BLK BlackRock	6.04 k	$18.54 mm	-93.7%
Tower Research Capital	1.49 k	$4.58 mm	-87.5%
UBS UBS	1.47 k	$4.51 mm	-91.0%

Largest transactions	Shares	Bought/sold	Change
22NW	537.00 k	-4.83 mm	-90.0%
Nantahala Capital Management	303.92 k	-2.79 mm	-90.2%
Renaissance Technologies	105.62 k	-957.23 k	-90.1%
Vanguard	85.82 k	-772.38 k	-90.0%
We Are One Seven	0.00	-171.42 k	EXIT
Geode Capital Management	14.74 k	-106.46 k	-87.8%
Perritt Capital Management	0.00	-100.00 k	EXIT
BLK BlackRock	6.04 k	-90.30 k	-93.7%
Azzad Asset Management	0.00	-67.00 k	EXIT
NTRS Northern Trust	0.00	-27.17 k	EXIT

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

SSKN insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
29 Oct 24	Christina L Allgeier	SSKN Stock Options Common Stock	Grant	Acquire A	No	No	3.175	20,000	63.50 k	20,000
15 Jul 24	Dolev Rafaeli	Common Stock	Buy	Acquire P	No	No	3.14	19,100	59.97 k	143,156
15 Jul 24	Accelmed Growth Partners	Common Stock	Buy	Acquire P	No	No	3.14	230,573	724.00 k	1,441,835

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro

12 Health Care Stocks Moving In Friday's Pre-Market Session

20 Dec 24

Strata Skin Sciences Q3 2024 GAAP EPS $(0.53) Beats $(0.57) Estimate, Sales $8.797M Beat $8.536M Estimate

13 Nov 24

Strata Skin Sciences (NASDAQ:SSKN) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.57) by 7.02 percent. The company reported quarterly sales of $8.797 million which beat

Earnings Scheduled For November 13, 2024

13 Nov 24

What to Expect from Strata Skin Sciences's Earnings

12 Nov 24

Press releases

From Benzinga Pro

STRATA Skin Sciences to Participate in the Benchmark Company 13th Annual Discovery Investor Conference

5 Dec 24

HORSHAM, Pa., Dec. 05, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. ("STRATA" or the "Company") (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative